{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T15:31:39Z","timestamp":1793633499855,"version":"4.5.1"},"reference-count":63,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Nucleic Acids"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.omtn.2026.103111","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T15:02:55Z","timestamp":1790175775000},"page":"103111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["AptViralDB: A repository of experimentally validated antiviral aptamers"],"prefix":"10.1016","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5075-5386","authenticated-orcid":false,"given":"Nisha","family":"Bajiya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1729-5746","authenticated-orcid":false,"given":"Shivansh","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-9868-358X","authenticated-orcid":false,"given":"Pushpendra Singh","family":"Gahlot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8902-2876","authenticated-orcid":false,"given":"Gajendra P.S.","family":"Raghava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2026.103111_bib1","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.4103\/jfmpc.jfmpc_2071_20","article-title":"Viral Pandemics in the Past Two Decades: An Overview","volume":"10","author":"Bhadoria","year":"2021","journal-title":"J. Fam. Med. Prim. Care"},{"key":"10.1016\/j.omtn.2026.103111_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.seps.2020.100898","article-title":"The dynamic effects of infectious disease outbreaks: The case of pandemic influenza and human coronavirus","volume":"71","author":"Verikios","year":"2020","journal-title":"Socioecon. Plann. Sci."},{"key":"10.1016\/j.omtn.2026.103111_bib3","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/s41586-021-03901-9","article-title":"Resurgence of Ebola virus in 2021 in Guinea suggests a new paradigm for outbreaks","volume":"597","author":"Keita","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2026.103111_bib4","article-title":"Influenza viruses - antiviral therapy and resistance","volume":"5","author":"Duwe","year":"2017","journal-title":"GMS Infect. Dis."},{"key":"10.1016\/j.omtn.2026.103111_bib5","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/s44259-025-00125-z","article-title":"Strategies and efforts in circumventing the emergence of antiviral resistance against conventional antivirals","volume":"3","author":"Aw","year":"2025","journal-title":"NPJ Antimicrob. Resist."},{"key":"10.1016\/j.omtn.2026.103111_bib6","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2165\/00002018-199410040-00002","article-title":"Adverse effects and drug interactions of clinical importance with antiviral drugs","volume":"10","author":"Morris","year":"1994","journal-title":"Drug Saf."},{"key":"10.1016\/j.omtn.2026.103111_bib7","doi-asserted-by":"crossref","first-page":"3904","DOI":"10.1111\/ene.16017","article-title":"Neurological side effects and drug interactions of antiviral compounds against SARS-CoV-2","volume":"30","author":"Akhvlediani","year":"2023","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.omtn.2026.103111_bib8","article-title":"Neuropsychiatric Effects of Antiviral Drugs","volume":"12","author":"Zareifopoulos","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.omtn.2026.103111_bib9","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/344467a0","article-title":"Selection in vitro of an RNA enzyme that specifically cleaves single-stranded DNA","volume":"344","author":"Robertson","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2026.103111_bib10","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/346818a0","article-title":"In vitro selection of RNA molecules that bind specific ligands","volume":"346","author":"Ellington","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2026.103111_bib11","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1126\/science.2200121","article-title":"Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase","volume":"249","author":"Tuerk","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.omtn.2026.103111_bib12","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1039\/C5AN01824B","article-title":"Aptamers in analytics","volume":"141","author":"Ilgu","year":"2016","journal-title":"Analyst"},{"key":"10.1016\/j.omtn.2026.103111_bib13","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/978-1-4939-6857-2_16","article-title":"Selection of Aptamers Against Whole Living Cells: From Cell-SELEX to Identification of Biomarkers","volume":"1575","author":"Quang","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.omtn.2026.103111_bib14","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.biochi.2017.11.019","article-title":"Aptamers targeting cell surface proteins","volume":"145","author":"Takahashi","year":"2018","journal-title":"Biochimie"},{"key":"10.1016\/j.omtn.2026.103111_bib15","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.chembiol.2015.01.005","article-title":"Cell-specific RNA aptamer against human CCR5 specifically targets HIV-1 susceptible cells and inhibits HIV-1 infectivity","volume":"22","author":"Zhou","year":"2015","journal-title":"Chem. Biol."},{"key":"10.1016\/j.omtn.2026.103111_bib16","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s10059-011-0156-x","article-title":"DNA aptamers against the receptor binding region of hemagglutinin prevent avian influenza viral infection","volume":"32","author":"Choi","year":"2011","journal-title":"Mol. Cells"},{"key":"10.1016\/j.omtn.2026.103111_bib17","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1089\/nat.2015.0564","article-title":"A DNA Aptamer Against Influenza A Virus: An Effective Inhibitor to the Hemagglutinin-Glycan Interactions","volume":"26","author":"Li","year":"2016","journal-title":"Nucleic Acid Therapeut."},{"key":"10.1016\/j.omtn.2026.103111_bib18","article-title":"Comparative Characterization of Diverse DNA Aptamers for Recognition of Spike Proteins of Multiple SARS-CoV-2 Variants","volume":"3","author":"Zhang","year":"2023","journal-title":"Anal. Sens."},{"key":"10.1016\/j.omtn.2026.103111_bib19","doi-asserted-by":"crossref","first-page":"10367","DOI":"10.1002\/ange.202100316","article-title":"A SARS-CoV-2 Spike Binding DNA Aptamer that Inhibits Pseudovirus Infection by an RBD-Independent Mechanism","volume":"133","author":"Schmitz","year":"2021","journal-title":"Angew. Chem. Weinheim. Bergstr. Ger."},{"key":"10.1016\/j.omtn.2026.103111_bib20","doi-asserted-by":"crossref","first-page":"5522","DOI":"10.7150\/thno.74428","article-title":"DNA aptamers inhibit SARS-CoV-2 spike-protein binding to hACE2 by an RBD- independent or dependent approach","volume":"12","author":"Silwal","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.omtn.2026.103111_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/ijms262211177","article-title":"Development of RNA Aptamers That Inhibit the RNA-Dependent RNA Polymerase Activity of SARS-CoV-2 Strains In Vitro","volume":"26","author":"Song","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omtn.2026.103111_bib22","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2015.1","article-title":"High-affinity RNA Aptamers Against the HIV-1 Protease Inhibit Both In Vitro Protease Activity and Late Events of Viral Replication","volume":"4","author":"Duclair","year":"2015","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2026.103111_bib23","doi-asserted-by":"crossref","first-page":"660","DOI":"10.3389\/fmicb.2020.00660","article-title":"Characterization of Novel Aptamers Specifically Directed to Red-Spotted Grouper Nervous Necrosis Virus (RGNNV)-Infected Cells for Mediating Targeted siRNA Delivery","volume":"11","author":"Zhou","year":"2020","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.omtn.2026.103111_bib24","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1373\/clinchem.2008.113514","article-title":"Generating aptamers for recognition of virus-infected cells","volume":"55","author":"Tang","year":"2009","journal-title":"Clin. Chem."},{"key":"10.1016\/j.omtn.2026.103111_bib25","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.3389\/fmicb.2019.01462","article-title":"Application of Aptamers in Virus Detection and Antiviral Therapy","volume":"10","author":"Zou","year":"2019","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.omtn.2026.103111_bib26","article-title":"Aptamers for Anti-Viral Therapeutics and Diagnostics","volume":"22","author":"Kim","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omtn.2026.103111_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/ph14070622","article-title":"Aptamer Applications in Emerging Viral Diseases","volume":"14","author":"Kr\u00fcger","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.omtn.2026.103111_bib28","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1021\/acsinfecdis.1c00546","article-title":"Aptamers for Viral Detection and Inhibition","volume":"8","author":"Chakraborty","year":"2022","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.omtn.2026.103111_bib29","doi-asserted-by":"crossref","first-page":"9500","DOI":"10.1021\/acsami.0c05750","article-title":"Recent Progress in Aptamer Discoveries and Modifications for Therapeutic Applications","volume":"13","author":"Ni","year":"2021","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.omtn.2026.103111_bib30","doi-asserted-by":"crossref","first-page":"17601","DOI":"10.1021\/acs.jmedchem.1c01567","article-title":"Aptamer-Based Antibacterial and Antiviral Therapy against Infectious Diseases","volume":"64","author":"Chen","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.omtn.2026.103111_bib31","doi-asserted-by":"crossref","first-page":"7331","DOI":"10.1039\/D0CS00617C","article-title":"Fundamental studies of functional nucleic acids: aptamers, riboswitches, ribozymes and DNAzymes","volume":"49","author":"Micura","year":"2020","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.omtn.2026.103111_bib32","article-title":"Structural basis of DNA aptamer A58 targeting the N-terminal domain of sarbecoviruses nucleocapsid protein","volume":"302","author":"Chen","year":"2026","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.omtn.2026.103111_bib33","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1002\/cbic.202000633","article-title":"Characterization of New DNA Aptamers for Anti-HIV-1 Reverse Transcriptase","volume":"22","author":"Ratanabunyong","year":"2021","journal-title":"Chembiochem"},{"key":"10.1016\/j.omtn.2026.103111_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/ijms27146386","article-title":"The Intrinsic Disordered N-Terminus of Nucleocapsid Protein of SARS-CoV-2 Is Critical in DNA Aptamer Binding","volume":"27","author":"Lu","year":"2026","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omtn.2026.103111_bib35","article-title":"Structural Biology for the Molecular Insight between Aptamers and Target Proteins","volume":"22","author":"Zhang","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omtn.2026.103111_bib36","doi-asserted-by":"crossref","first-page":"421","DOI":"10.3390\/molecules21040421","article-title":"Methods for Improving Aptamer Binding Affinity","volume":"21","author":"Hasegawa","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.omtn.2026.103111_bib37","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.4548","article-title":"Binding Affinity Measurements Between DNA Aptamers and their Virus Targets Using ELONA and MST","volume":"12","author":"Pawel","year":"2022","journal-title":"Bio. Protoc."},{"key":"10.1016\/j.omtn.2026.103111_bib38","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s12551-024-01252-z","article-title":"Analyzing aptamer structure and interactions: in silico modelling and instrumental methods","volume":"16","author":"Malysheva","year":"2024","journal-title":"Biophys. Rev."},{"key":"10.1016\/j.omtn.2026.103111_bib39","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/1062936X.2018.1558416","article-title":"Prediction of the binding affinity of aptamers against the influenza virus","volume":"30","author":"Yu","year":"2019","journal-title":"SAR QSAR Environ. Res."},{"key":"10.1016\/j.omtn.2026.103111_bib40","article-title":"Design and Prediction of Aptamers Assisted by In Silico Methods","volume":"11","author":"Lee","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.omtn.2026.103111_bib41","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1021\/acs.jcim.3c00713","article-title":"APIPred: An XGBoost-Based Method for Predicting Aptamer-Protein Interactions","volume":"64","author":"Fang","year":"2024","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.omtn.2026.103111_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2024.102358","article-title":"AptamerRunner: An accessible aptamer structure prediction and clustering algorithm for visualization of selected aptamers","volume":"35","author":"Ruiz-Ciancio","year":"2024","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2026.103111_bib43","doi-asserted-by":"crossref","first-page":"D1147","DOI":"10.1093\/nar\/gkt1191","article-title":"AVPdb: a database of experimentally validated antiviral peptides targeting medically important viruses","volume":"42","author":"Qureshi","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2026.103111_bib44","doi-asserted-by":"crossref","DOI":"10.1038\/srep32713","article-title":"ZikaVR: An Integrated Zika Virus Resource for Genomics, Proteomics, Phylogenetic and Therapeutic Analysis","volume":"6","author":"Gupta","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtn.2026.103111_bib45","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1089\/mab.2020.0035","article-title":"A Web-Based Platform on Coronavirus Disease-19 to Maintain Predicted Diagnostic, Drug, and Vaccine Candidates","volume":"39","author":"Patiyal","year":"2020","journal-title":"Monoclon. Antibodies Immunodiagn. Immunother."},{"key":"10.1016\/j.omtn.2026.103111_bib46","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/s41597-022-01394-3","article-title":"A database of anti-coronavirus peptides","volume":"9","author":"Zhang","year":"2022","journal-title":"Sci. Data"},{"key":"10.1016\/j.omtn.2026.103111_bib47","doi-asserted-by":"crossref","DOI":"10.1093\/bioinformatics\/btae305","article-title":"DeepAVP-TPPred: identification of antiviral peptides using transformed image-based localized descriptors and binary tree growth algorithm","volume":"40","author":"Ullah","year":"2024","journal-title":"Bioinformatics"},{"key":"10.1016\/j.omtn.2026.103111_bib48","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-11328-9","article-title":"A hybrid framework of generative deep learning for antiviral peptide discovery","volume":"15","author":"Duy","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtn.2026.103111_bib49","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1109\/TCBBIO.2024.3524607","article-title":"Datt-AVP: Antiviral Peptide Prediction by Sequence-Based Dual Channel Network With Attention Mechanism","volume":"22","author":"Sun","year":"2025","journal-title":"IEEE Trans. Comput. Biol. Bioinform."},{"key":"10.1016\/j.omtn.2026.103111_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2026.169628","article-title":"DRAVP 2.0: A Curated and Genomically Annotated Database of Antiviral Peptides and Proteins","volume":"438","author":"Nawaz","year":"2026","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.omtn.2026.103111_bib51","doi-asserted-by":"crossref","first-page":"D95","DOI":"10.1093\/nar\/gkh094","article-title":"Aptamer database","volume":"32","author":"Lee","year":"2004","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2026.103111_bib52","doi-asserted-by":"crossref","DOI":"10.1093\/database\/bas006","article-title":"Aptamer Base: a collaborative knowledge base to describe aptamers and SELEX experiments","volume":"2012","author":"Cruz-Toledo","year":"2012","journal-title":"Database."},{"key":"10.1016\/j.omtn.2026.103111_bib53","doi-asserted-by":"crossref","first-page":"D351","DOI":"10.1093\/nar\/gkad959","article-title":"UTexas Aptamer Database: the collection and long-term preservation of aptamer sequence information","volume":"52","author":"Askari","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2026.103111_bib54","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1261\/rna.079784.123","article-title":"AptaDB: a comprehensive database integrating aptamer-target interactions","volume":"30","author":"Chen","year":"2024","journal-title":"RNA"},{"key":"10.1016\/j.omtn.2026.103111_bib55","doi-asserted-by":"crossref","first-page":"D264","DOI":"10.1093\/nar\/gkaf1016","article-title":"Ribocentre-aptamer: an integrative, structure-focused database for RNA aptamers","volume":"54","author":"Lu","year":"2026","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2026.103111_bib56","first-page":"2166","article-title":"Selection of 2\u2019-Deoxy-2'-Fluoroarabino Nucleic Acid (FANA) Aptamers That Bind HIV-1 Integrase with Picomolar Affinity","volume":"14","author":"Rose","year":"2019","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.omtn.2026.103111_bib57","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28124645","article-title":"Structure-Guided Development of Bivalent Aptamers Blocking SARS-CoV-2 Infection","volume":"28","author":"Rahman","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.omtn.2026.103111_bib58","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.omtn.2021.07.015","article-title":"The role of SAXS and molecular simulations in 3D structure elucidation of a DNA aptamer against lung cancer","volume":"25","author":"Morozov","year":"2021","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2026.103111_bib59","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/978-1-0716-2695-5_9","article-title":"Determination of Aptamer Structure Using Circular Dichroism Spectroscopy","volume":"2570","author":"Kerler","year":"2023","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.omtn.2026.103111_bib60","doi-asserted-by":"crossref","DOI":"10.1007\/s10822-026-00800-x","article-title":"In silico aptamer design: from sequence selection to structural optimization and computational modelling strategies","volume":"40","author":"Sinharay","year":"2026","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.omtn.2026.103111_bib61","article-title":"Advances in RNA secondary structure prediction and RNA modifications: Methods, data, and applications","author":"Yang","year":"2025","journal-title":"arXiv"},{"key":"10.1016\/j.omtn.2026.103111_bib62","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1006768","article-title":"Structure, stability and specificity of the binding of ssDNA and ssRNA with proteins","volume":"15","author":"Pal","year":"2019","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.omtn.2026.103111_bib63","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1748-7188-6-26","article-title":"ViennaRNA Package 2.0","volume":"6","author":"Lorenz","year":"2011","journal-title":"Algorithm Mol. Biol."}],"container-title":["Molecular Therapy Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253126002829?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253126002829?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T15:14:48Z","timestamp":1793632488000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253126002829"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":63,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["S2162253126002829"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2026.103111","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AptViralDB: A repository of experimentally validated antiviral aptamers","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2026.103111","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"103111"}}